Immune activation in Africa is environmentally-driven and is associated with upregulation of CCR5

AIDS

Volumn 14, Issue 14, 2000, Pages 2083-2092

  Clerici, Mario ^a   Butto, Stefano ^b   Lukwiya, Matthew ^c   Saresella, Marina ^a   Declich, Silvia ^b   Trabattoni, Daria ^a   Pastori, Claudia ^d   Piconi, Stefania ^e   Fracasso, Claudio ^b   Fabiani, Massimo ^b   Ferrante, Pasquale ^a   Rizzardini, Giuliano ^e   Lopalco, Lucia ^d  

^a UNIVERSITY OF MILAN   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c St Mary's Hospital Lacor Uganda   (Uganda)

^d SAN RAFFAELE HOSPITAL   (Italy)

^e Divisione di Malattie Infettive   (Italy)

Author keywords

Africa; Chemokine receptors; HIV; Immune activation; Immunology; Viral quasispecies

Indexed keywords

CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; MESSENGER RNA; VIRUS RECEPTOR;

AFRICA; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; IMMUNOREGULATION; IMMUNOSTIMULATION; PRIORITY JOURNAL; VIRUS ISOLATION; VIRUS STRAIN;

AFRICA; HIV ANTIBODIES; HIV INFECTIONS; HIV SERONEGATIVITY; HIV SEROPOSITIVITY; HIV-1; HUMANS; ITALY; NEUTRALIZATION TESTS; POLYMERASE CHAIN REACTION; RECEPTORS, CCR5; RECEPTORS, CXCR4; RNA, MESSENGER;

EID: 0033791524     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200009290-00003     Document Type: Article

References (41)

1. Immune activation is a dominant factor in the pathogenesis of African AIDS
2. Immunologic activation markers in the serum of African and European HIV seropositive and seronegative individuals
3. Immune activation in HIV-infected African individuals
4. Seroconversion rate, mortality and clinical manifestations associated with the receipt of an HIV infected blood transfusion in Kinshasa, Zaire
5. HIV infection amongst employees in an African hospital
6. Survival time of patients with AIDS: Experience with 274 patients in Dar el Salam
7. Comparison of the declines in CD4 counts in HIV-1 seropositive female sex workers and women from the general population in Nairobi, Kenya
8. The epidemiology of HIV infection and AIDS in Africa
9. Natural history and spectrum of disease in adults with HIV/AIDS in Africa
10. Interleukin-2 regulates CC receptor expression and chemotactic responsiveness in T lymphocytes
11. Interleukin-10 increases CCR5 expression and HIV infection in human monocytes
12. The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes
13. Dual effect of IL-4 on HIV-1 expression. Implications for viral phenotypic switch and disease progression
14. Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype
15. HIV phenotype and interleukin-2/interleukin-10 ratio are associated markers of protection and progression in HIV infection
16. HIV-1 subtype C viruses from Ethiopian AIDS patients are preferentially nonsyncytium inducing (NSI)
17. Genetic and biological characterization of HIV-1 strains from Cameroon
18. Characterization of HIV-1 isolates from Tanzania
19. HIV-1 subtpe C syncytium- and non syncytium-inducing phenotypes and coreceptor usage among Ethiopian patients with AIDS
20. Serologic and phylogenetic characterization of HIV-1 subtypes in Uganda
21. MT-2 cell tropism as prognostic marker for disease progression in human immunodeficiency type I infection
22. CD4+CD7-CD57+ T cells: A new T lymphocyte subset expanded during HIV infection
23. A Th0/Th2-like function of CD4+ CD7+ T helper cells from normal donors and HIV infected patients
24. Global distribution of human HIV-1 clades
25. Genetic diversity and HIV detection by polymerase chain reaction
26. Syncytium-inducing and non-syncytium-inducing capacity of human immunodeficiency virus type I subtypes other than B: Phenotypic and genotypic characteristics. WHO network isolation and characterization
27. Replicative capacity of human immunodeficiency virus from patients with varying severity of infection
28. Biologic features of HIV-1 that correlate with virulence in the host
29. Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: Progression of disease is associated with a shift from monocytotropic to T-cell tropic virus population
30. Virions of primary human immunodeficiency virus type I isolates resistant to soluble CD4 (sCD4) neutralization differ in sCD4 binding and glycoprotein gp120 retention from sCD4-sensitive isolates
31. Adaptation to promiscuous usage of CC and CXC chemokine coreceptors in vivo correlates with HIV-1 disease progression
32. Association between CCR5 genotype and the clinical course of HIV-1 infection
33. Increased CCR5 expression with decreased beta chemokine secretion in Ethiopians: Relevance to AIDS in Africa
34. Pathogenesis of AIDS in Africa. Lesson from the Ethiopian immigrants in Israel
35. Neutralization profiles of primary immunodeficiency virus type I Isolates in the context of coreceptor usage
36. Neutralization sensitivity of human immunodeficiency virus type I primary isolates to antibodies and CD4-based reagents is independent of coreceptor usage
37. Differences in chemokine coreceptor usage between genetic subtypes of HIV-1
38. Genetic subtype-independent inhibition of HIV type I replication by CC and CXC chemokines
39. Infectious cellular load in human immmunodeficiency virus type 1 (HIV-1)-infected individuals and susceptibility of peripheral blood mononuclear cells from their exposed partners to non-syncytium-inducing HIV-1 as major determinants for HIV-1 transmission in homosexual couples
40. Evidence that antibody-mediated neutralization of human immunodeficiency virus type 1 by sera from infected individuals is independent of coreceptor usage
41. Repertoire of chemokine receptors in the female genital tract: Implications for HIV transmission